Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Vaccines

Free Subscription Articles published in Virus Res Retrieve available abstracts of 22 articles: HTML format Text format

Single Articles

May 2018
1. SHOKOUHI H, Farahmand B, Ghaemi A, Mazaheri V, et al
   Vaccination with three tandem repeats of M2 extracellular domain fused to Leismania major HSP70 protects mice against influenza A virus challenge.
   Virus Res. 2018;251:40-46.
   PubMed     Text format     Abstract available
   
   
   January 2018
2. BHATT M, Mohapatra JK, Pandey LK, Mohanty NN, et al
   Mutational analysis of foot and mouth disease virus nonstructural polyprotein 3AB-coding region to design a negative marker virus.
   Virus Res. 2018;243:36-43.
   PubMed     Text format     Abstract available
   
   
   December 2017
3. KIM SC, Won YH, Park JS, Jeon JS, et al
   Vaccine-Type Mutations Identified in Varicella Zoster Virus Passaged in Cell Culture.
   Virus Res. 2017 Dec 11. pii: S0168-1702(17)30833.
   PubMed     Text format     Abstract available
   
   
   September 2017
4. WANG Y, Zhang Y, Wu J, Lin Y, et al
   Recombinant influenza H7 hemagglutinin containing CFLLC minidomain in the transmembrane domain showed enhanced cross-protection in mice.
   Virus Res. 2017;242:16-23.
   PubMed     Text format     Abstract available
   
   
   June 2017
5. ZHANG X, Qin C, Li W, Zheng Z, et al
   Isolation and Characterization of a Highly Evolved Type 3 Vaccine-Derived Poliovirus in China.
   Virus Res. 2017 Jun 29. pii: S0168-1702(17)30314.
   PubMed     Text format     Abstract available
   
   
   May 2017
6. LI Y, Yan S, Li X, Yang Q, et al
   From mouse to pig: is PRV vaccine safe across two species?
   Virus Res. 2017 May 5. pii: S0168-1702(17)30197.
   PubMed     Text format     Abstract available
   
   
   April 2017
7. MUNOZ-ALIA MA, Casasnovas JM, Celma ML, Carabana J, et al
   Measles Virus Hemagglutinin epitopes immunogenic in natural infection and vaccination are targeted by broad or genotype-specific neutralizing monoclonal antibodies.
   Virus Res. 2017 Apr 29. pii: S0168-1702(17)30127.
   PubMed     Text format     Abstract available
   
   
   
8. FULTON RW, Neill JD, Saliki JT, Landis C, et al
   Genomic and antigenic characterization of bovine parainfluenza-3 viruses in the United States including modified live virus vaccine (MLV) strains and field strains from cattle.
   Virus Res. 2017 Apr 14. pii: S0168-1702(17)30110.
   PubMed     Text format     Abstract available
   
   
   March 2017
9. MA Y, Lu Y, Guan G, Luo J, et al
   Flower-like ZnO nanostructure assisted loop-mediated isothermal amplification assay for detection of Japanese encephalitis virus.
   Virus Res. 2017;232:34-40.
   PubMed     Text format     Abstract available
   
   
   
10. CHRISTENSEN ND, Budgeon LR, Cladel NM, Hu J, et al
    Recent advances in preclinical model systems for papillomaviruses.
    Virus Res. 2017;231:108-118.
    PubMed     Text format     Abstract available
    
    
    February 2017
11. MANJUNATH S, Mishra BP, Mishra B, Sahoo AP, et al
    Comparative and temporal transcriptome analysis of peste des petits ruminants virus infected goat peripheral blood mononuclear cells.
    Virus Res. 2017;229:28-40.
    PubMed     Text format     Abstract available
    
    
    
12. CZARNECKI MW, Traktman P
    The vaccinia virus DNA polymerase and its processivity factor.
    Virus Res. 2017 Feb 1. pii: S0168-1702(16)30833.
    PubMed     Text format     Abstract available
    
    
    January 2017
13. STACHYRA A, Pietrzak M, Maciola A, Protasiuk A, et al
    A prime/boost vaccination with HA DNA and Pichia-produced HA protein elicits a strong humoral response in chickens against H5N1.
    Virus Res. 2017;232:41-47.
    PubMed     Text format     Abstract available
    
    
    December 2016
14. YANG A, Farmer E, Lin J, Wu TC, et al
    The current state of therapeutic and T cell-based vaccines against human papillomaviruses.
    Virus Res. 2016 Dec 5. pii: S0168-1702(16)30556.
    PubMed     Text format     Abstract available
    
    
    November 2016
15. SCHELLENBACHER C, Roden RB, Kirnbauer R
    Developments in L2-based Human Papillomavirus (HPV) Vaccines.
    Virus Res. 2016 Nov 23. pii: S0168-1702(16)30528.
    PubMed     Text format     Abstract available
    
    
    September 2016
16. ILLIANO E, Bissa M, Paolini F, Zanotto C, et al
    Prime-boost therapeutic vaccination in mice with DNA/DNA or DNA/Fowlpox virus recombinants expressing the Human Papilloma Virus type 16 E6 and E7 mutated proteins fused to the coat protein of Potato virus X.
    Virus Res. 2016;225:82-90.
    PubMed     Text format     Abstract available
    
    
    August 2016
17. CRAWFORD K, Lager KM, Kulshreshtha V, Miller LC, et al
    Status of vaccines for porcine epidemic diarrhea virus in the United States and Canada.
    Virus Res. 2016 Aug 18. pii: S0168-1702(16)30366.
    PubMed     Text format     Abstract available
    
    
    
18. KIM BC, Kim DK, Kim HJ, Hong SH, et al
    A collaborative study of an alternative in vitro potency assay for the Japanese encephalitis vaccine.
    Virus Res. 2016;223:190-196.
    PubMed     Text format     Abstract available
    
    
    July 2016
19. ZUNIGA S, Pascual-Iglesias A, Sanchez CM, Sola I, et al
    VIRULENCE FACTORS IN PORCINE CORONAVIRUSES AND VACCINE DESIGN.
    Virus Res. 2016 Jul 7. pii: S0168-1702(16)30399.
    PubMed     Text format     Abstract available
    
    
    June 2016
20. FULTON RW, d'Offay JM, Dubovi EJ, Eberle R, et al
    Bovine Herpesvirus-1: Genetic Diversity of Field Strains from Cattle with Respiratory Disease, Genital, Fetal Disease and Systemic Neonatal Disease and Their Relationship to Vaccine Strains.
    Virus Res. 2016 Jun 29. pii: S0168-1702(16)30231.
    PubMed     Text format     Abstract available
    
    
    May 2016
21. LANGEL SN, Paim FC, Lager KM, Vlasova AN, et al
    Lactogenic Immunity and Vaccines for Porcine Epidemic Diarrhea Virus (PEDV): Historical And Current Concepts.
    Virus Res. 2016 May 19. pii: S0168-1702(16)30215.
    PubMed     Text format     Abstract available
    
    
    
22. TERASAKI K, Tercero BR, Makino S
    Single-cycle replicable Rift Valley fever virus mutants as safe vaccine candidates.
    Virus Res. 2016;216:55-65.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: